Skip to content Skip to sidebar Skip to footer
Subscribe Now
Viewpoints_Dr. Minnie Sarwal
VIEWPOINTS

PharmaShots Interview: NephroSant’s Dr. Minnie Sarwal Shares Insights on QSant and the Need for Precision Medicine in Kidney Health

In an interview with PharmaShots, Dr. Minnie Sarwal, CEO and Co-Founder of NephroSant shares her view on the QSant and how this urine test can improve outcomes for transplant patients. She also shed light on the need for precision therapies in kidney transplant care.Shots:NephroSant's Qsant is a needle-free urine test that helps in determining if…
July 7, 20210Comments

Read more

Viewpoints_Juan Camilo Arjona Ferreira
VIEWPOINTS

PharmaShots Interview: Myovant’s Juan Camilo Arjona Ferreira Shares Insights on the Ryeqo

In an interview with PharmaShots, Myovant's Juan Camilo Arjona Ferreira, MD, Chief Medical Officer of Myovant Sciences shares his views on the CHMP's positive opinion for Ryeqo (Relugolix Combination Tablet).Shots:The CHMP has adopted positive opinion recommending approval of Ryeqo (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) for the treatment of…
July 5, 20210Comments

Read more

Viewpoints_Dr. Jan Wehkamp and Dr. Bruce Sands
VIEWPOINTS

PharmaShots Interview: Janssen’s Dr. Jan Wehkamp and Icahn School of Medicine’s Dr. Bruce Sands Share Insights on the Data Presented at DDW 2021

In an interview with PharmaShots, Dr. Jan Wehkamp, M.D., Vice President, Gastroenterology Disease Area Leader at Janssen, and Bruce Sands, Dr. Burrill B. Crohn Professor of Medicine at the Icahn School of Medicine share their views on the data of Stelara and Tremfya presented at DDW 2021.Shots:Janssen presented the new data on Stelara (ustekinumab) and…
July 2, 20210Comments

Read more

Viewpoints_Andrea DiFabio
VIEWPOINTS

PharmaShots Interview: Repertoire’s Andrea DiFabio Shares Insights on the Importance of Series B Funding

In an interview with PharmaShots, Andrea DiFabio, JD, Chief Legal and Administration Officer of Repertoire Immune Medicines shares her views on the importance of $189M series B funding and how it will support the company's pipeline and manufacturing plans.Shots:The company reported the completion of a $189 million Series B financing. Founded by Flagship…
June 30, 20210Comments

Read more

Viewpoints_Nathalie Landry
VIEWPOINTS

PharmaShots Interview: Medicago’s Nathalie Landry Shares Insights on the Phase 2 Results of Plant-Based COVID-19 Vaccine

In an Interview with PharmaShots, Nathalie Landry, Executive Vice President, Scientific, and Medical Affairs at Medicago share her views on the P-II results of adjuvanted plant-based COVID-19 vaccine.Shots:The P-II study involves assessing the safety & immunogenicity of the CoVLP vs PBO in 306 subjects aged =18yrs. with two age groups (18-64yrs & over 65yrs.) across…
June 29, 20210Comments

Read more

Viewpoints_Kevin Cammack
VIEWPOINTS

PharmaShots Interview: Eli Lilly’s Kevin Cammack Shares Insights on Lilly’s Collaboration with Global Diabetes Technology Companies

In an interview with PharmaShots, Kevin Cammack, Head of Connected Care, Eli Lilly and Company shares insights on the Lilly alliance with DexCom, Glooko, myDiabby Healthcare, and Roche to provide compatibility between their unique digital management platforms and Lilly's Tempo Pen and Tempo Smart Button.Shots:Eli Lilly collaborates with DexCom, Glooko, myDiabby Healthcare, and Roche to…
June 28, 20210Comments

Read more

Thoughtspot_Sunaina Anand
THOUGHTSPOT

Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment

The pandemic has led to the identification of some promising nutraceuticals for the management and prevention of Covid-19. Nutraceuticals with their immune-boosting potential can amplify the body's defense system against the virus. For the past numerous decades, the medicinal action of natural compounds has gained focus as an alternate or adjuvant therapy approach in treating…
June 24, 20210Comments

Read more